ArticleAnnals of oncology : official journal of the European Society for Medical Oncology2021

Reply to: 'Real-world prevalence across 159 872 patients with cancer supports the clinical utility of TMB-H to define metastatic solid tumors for treatment with pembrolizumab.' by D. Fabrizio et al.

D J McGrail et al.PubMed ↗Publisher ↗

No numbers read from the abstract.